Dr. Marty Makary

And actually the lipidology community is, has evolved entirely independent of the cardiology community. So the cardiologists kind of claimed lipid science at a certain point, but the lipidology community is like, hey, wait a minute, we've been studying this for a long time with hyperlipidemia, and they have very different views on things.

And actually the lipidology community is, has evolved entirely independent of the cardiology community. So the cardiologists kind of claimed lipid science at a certain point, but the lipidology community is like, hey, wait a minute, we've been studying this for a long time with hyperlipidemia, and they have very different views on things.

And actually the lipidology community is, has evolved entirely independent of the cardiology community. So the cardiologists kind of claimed lipid science at a certain point, but the lipidology community is like, hey, wait a minute, we've been studying this for a long time with hyperlipidemia, and they have very different views on things.

So for example, lipoprotein A testing was recognized in the lipidology community as saving lives, as you mentioned, but not in the cardiology community because all their tests just use the crude LDL. Right.

So for example, lipoprotein A testing was recognized in the lipidology community as saving lives, as you mentioned, but not in the cardiology community because all their tests just use the crude LDL. Right.

So for example, lipoprotein A testing was recognized in the lipidology community as saving lives, as you mentioned, but not in the cardiology community because all their tests just use the crude LDL. Right.

So I went to the head of the cardiology lipid center at Hopkins and I asked him, I said, I've been reading about LP little a, seems like it should be this subject of a massive universal public health campaign to get everyone to get it done. It'd be a lot better than trying to get a defibrillator in every bathroom in the mall, which is actually a real campaign Hopkins champion. Yeah.

So I went to the head of the cardiology lipid center at Hopkins and I asked him, I said, I've been reading about LP little a, seems like it should be this subject of a massive universal public health campaign to get everyone to get it done. It'd be a lot better than trying to get a defibrillator in every bathroom in the mall, which is actually a real campaign Hopkins champion. Yeah.

So I went to the head of the cardiology lipid center at Hopkins and I asked him, I said, I've been reading about LP little a, seems like it should be this subject of a massive universal public health campaign to get everyone to get it done. It'd be a lot better than trying to get a defibrillator in every bathroom in the mall, which is actually a real campaign Hopkins champion. Yeah.

Saves lives for sure. Saves lives. But like here's something that's so – heart disease is the number one cause of death. So he acknowledged, yeah, there's some new research and we did put it in our new guidelines. I'm like, you know what? I read those guidelines, American College of Cardiology. It was a footnote. Like where's the enthusiasm? Where's the vigor?

Saves lives for sure. Saves lives. But like here's something that's so – heart disease is the number one cause of death. So he acknowledged, yeah, there's some new research and we did put it in our new guidelines. I'm like, you know what? I read those guidelines, American College of Cardiology. It was a footnote. Like where's the enthusiasm? Where's the vigor?

Saves lives for sure. Saves lives. But like here's something that's so – heart disease is the number one cause of death. So he acknowledged, yeah, there's some new research and we did put it in our new guidelines. I'm like, you know what? I read those guidelines, American College of Cardiology. It was a footnote. Like where's the enthusiasm? Where's the vigor?

Where's the – it's just like molasses sometimes. Yeah.

Where's the – it's just like molasses sometimes. Yeah.

Where's the – it's just like molasses sometimes. Yeah.

There is a drug in phase three clinical trial that targets lipoprotein little a. So we'll see what the results of that show. But I wonder if, you know, those are the people you want to just be more aggressive on maybe.

There is a drug in phase three clinical trial that targets lipoprotein little a. So we'll see what the results of that show. But I wonder if, you know, those are the people you want to just be more aggressive on maybe.

There is a drug in phase three clinical trial that targets lipoprotein little a. So we'll see what the results of that show. But I wonder if, you know, those are the people you want to just be more aggressive on maybe.

and track. And maybe you get the cardiac CT angio on them instead of just a calcium score. Those are the ones.

and track. And maybe you get the cardiac CT angio on them instead of just a calcium score. Those are the ones.